Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Blood|September 1, 2005
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaJohn G Gribben, David Zahrieh, Katherine Stephans, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Haematologica|August 26, 2021
Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformationHaesook T Kim, Peter O Baker, Erin Parry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor graftsYi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantationEdwin P Alyea, Edie Weller, David C Fisher, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Blood|September 1, 2005
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaJohn G Gribben, David Zahrieh, Katherine Stephans, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Haematologica|August 26, 2021
Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformationHaesook T Kim, Peter O Baker, Erin Parry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor graftsYi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantationEdwin P Alyea, Edie Weller, David C Fisher, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemiaYi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Pageof 18